These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17673493)

  • 1. Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis.
    Lin X; Tench CR; Morgan PS; Constantinescu CS
    J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):437-41. PubMed ID: 17673493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Importance sampling' in MS: use of diffusion tensor tractography to quantify pathology related to specific impairment.
    Lin X; Tench CR; Morgan PS; Niepel G; Constantinescu CS
    J Neurol Sci; 2005 Oct; 237(1-2):13-9. PubMed ID: 16109428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis.
    Caligiuri ME; Barone S; Cherubini A; Augimeri A; Chiriaco C; Trotta M; Granata A; Filippelli E; Perrotta P; Valentino P; Quattrone A
    Neuroimage Clin; 2015; 7():28-33. PubMed ID: 25610764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R; De Masi R; Nasuelli D; Bragadin LM; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    Neuroradiology; 2001 Apr; 43(4):272-8. PubMed ID: 11338408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.
    Barone S; Caligiuri ME; Valentino P; Cherubini A; Chiriaco C; Granata A; Filippelli E; Tallarico T; Nisticò R; Quattrone A
    J Neurol; 2018 Oct; 265(10):2243-2250. PubMed ID: 30051273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion tensor fractional anisotropy of the normal-appearing seven segments of the corpus callosum in healthy adults and relapsing-remitting multiple sclerosis patients.
    Hasan KM; Gupta RK; Santos RM; Wolinsky JS; Narayana PA
    J Magn Reson Imaging; 2005 Jun; 21(6):735-43. PubMed ID: 15906348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion tensor imaging of corpus callosum integrity in multiple sclerosis: correlation with disease variables.
    Sigal T; Shmuel M; Mark D; Gil H; Anat A
    J Neuroimaging; 2012 Jan; 22(1):33-7. PubMed ID: 21122007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities.
    Traboulsee A; Dehmeshki J; Peters KR; Griffin CM; Brex PA; Silver N; Ciccarrelli O; Chard DT; Barker GJ; Thompson AJ; Miller DH
    Mult Scler; 2003 Dec; 9(6):566-73. PubMed ID: 14664468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study.
    Llufriu S; Blanco Y; Martinez-Heras E; Casanova-Molla J; Gabilondo I; Sepulveda M; Falcon C; Berenguer J; Bargallo N; Villoslada P; Graus F; Valls-Sole J; Saiz A
    PLoS One; 2012; 7(5):e37167. PubMed ID: 22606347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
    Yaldizli Ö; Penner IK; Frontzek K; Naegelin Y; Amann M; Papadopoulou A; Sprenger T; Kuhle J; Calabrese P; Radü EW; Kappos L; Gass A
    Mult Scler; 2014 Mar; 20(3):356-64. PubMed ID: 23959709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.
    Oreja-Guevara C; Charil A; Caputo D; Cavarretta R; Sormani MP; Filippi M
    Arch Neurol; 2006 May; 63(5):736-40. PubMed ID: 16682543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing-remitting multiple sclerosis.
    Sánchez MP; Nieto A; Barroso J; Martín V; Hernández MA
    Eur J Neurol; 2008 Oct; 15(10):1091-9. PubMed ID: 18727673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal appearing white matter permeability: a marker of inflammation and information processing speed deficit among relapsing remitting multiple sclerosis patients.
    Eftekhari E; Hojjat SP; Vitorino R; Carroll TJ; Cantrell CG; Lee L; Taylor MW; Morrow SA; Benhabib H; Aviv RI; Kassner A
    Neuroradiology; 2017 Aug; 59(8):771-780. PubMed ID: 28623483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis.
    Deloire MS; Salort E; Bonnet M; Arimone Y; Boudineau M; Amieva H; Barroso B; Ouallet JC; Pachai C; Galliaud E; Petry KG; Dousset V; Fabrigoule C; Brochet B
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):519-26. PubMed ID: 15774439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and Index.
    Granberg T; Bergendal G; Shams S; Aspelin P; Kristoffersen-Wiberg M; Fredrikson S; Martola J
    J Neuroimaging; 2015; 25(6):996-1001. PubMed ID: 25786805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corpus callosum axon diameter relates to cognitive impairment in multiple sclerosis.
    Huang SY; Fan Q; Machado N; Eloyan A; Bireley JD; Russo AW; Tobyne SM; Patel KR; Brewer K; Rapaport SF; Nummenmaa A; Witzel T; Sherman JC; Wald LL; Klawiter EC
    Ann Clin Transl Neurol; 2019 May; 6(5):882-892. PubMed ID: 31139686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corpus callosum damage and cognitive dysfunction in benign MS.
    Mesaros S; Rocca MA; Riccitelli G; Pagani E; Rovaris M; Caputo D; Ghezzi A; Capra R; Bertolotto A; Comi G; Filippi M
    Hum Brain Mapp; 2009 Aug; 30(8):2656-66. PubMed ID: 19067325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
    De Stefano N; Battaglini M; Stromillo ML; Zipoli V; Bartolozzi ML; Guidi L; Siracusa G; Portaccio E; Giorgio A; Sorbi S; Federico A; Amato MP
    Brain; 2006 Aug; 129(Pt 8):2008-16. PubMed ID: 16815879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.